The new facility will go online in the second half of 2022, with 100 new staff to be recruited, Lonza added in a statement.
(Reporting by Michael Shields; Editing by Michelle Martin)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
521.9 CHF | +1.58% | +3.62% | +47.30% |
Apr. 18 | Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix... | |
Apr. 18 | Lonza Finance Launches EUR1 Billion 12-Year Euro Bond | DJ |
Swiss contract manufacturer Lonza Group is adding a mid-scale microbial facility to supply France's Laboratoires Servier with active pharmaceutical ingredient for acute lymphoblastic leukaemia therapies, Lonza said on Tuesday.
The new facility will go online in the second half of 2022, with 100 new staff to be recruited, Lonza added in a statement.
(Reporting by Michael Shields; Editing by Michelle Martin)
1st Jan change | Capi. | |
---|---|---|
+47.30% | 40.57B | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B | |
-18.79% | 9.85B |